First COVID-19 nasal spray vaccine being developed by Dartmouth Health, the NIH and Exothera healthcarefinancenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcarefinancenews.com Daily Mail and Mail on Sunday newspapers.
Dartmouth is part of research for nasal spray COVID vaccine concordmonitor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from concordmonitor.com Daily Mail and Mail on Sunday newspapers.
Health experts say the Omicron subvariant BA.2.12.1 often causes mild symptoms in vaccinated individuals within a week. Here's how long breakthrough COVID-19 symptoms last on average.